About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDNCT01453062

Phase IV Observational Study in Chronic Lymphocytic Leukemia

B-cell chronic lymphocytic leukemia (CLL) is a subtype of mature peripheral B-cell neoplasms, characterized by the accumulation of circulating malignant lymphocytes that typically express cell surface...

Lead sponsor: GlaxoSmithKline•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

GlaxoSmithKline

Age

All ages

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•All CLL patients who have previously received Arzerra, whether alive or deceased
•Patients who have either completed the full course of Arzerra therapy or discontinued treatment early

Exclusion Criteria

•CLL patients newly initiating Arzerra
•Patients having been treated with Arzerra in phase II or phase III clinical trials

Related studies

COMPLETEDPhase 3

Ofatumumab Added to Fludarabine-Cyclophosphamide vs Fludarabine-Cyclophosphamide Combination in Relapsed Subjects With Chronic Lymphocytic Leukemia

NCT00824265 · Leukaemia, Lymphocytic, Chronic

COMPLETEDPhase 1

Ofatumumab in Japanese Patients With CD20 Positive Follicular Lymphoma or Chronic Lymphocytic Leukemia

NCT00742144 · Leukaemia, Lymphocytic, Chronic and Lymphoma, Follicular

COMPLETEDPhase 2

A Phase I/II, a Single Arm, Open-label Study of Ofatumumab (GSK1841157) in Patients With Previously Treated Chronic Lymphocytic Leukemia

NCT01077622 · Leukaemia, Lymphocytic, Chronic

COMPLETEDPhase 2

A Phase I/II, Open-label Study of Ofatumumab Added to Chlorambucil in Previously Untreated Japanese Patients With Chronic Lymphocytic Leukemia

NCT01563055 · Leukaemia, Lymphocytic, Chronic

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: July 8, 2014Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment1

Start dateSep 2011

Last updatedJul 8, 2014

Condition

Leukaemia, Lymphocytic, Chronic

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: July 8, 2014Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions